Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-γ and IFN-β:: Critical role of STAT-1α

被引:133
作者
Ma, ZD [1 ]
Qin, HW [1 ]
Benveniste, EN [1 ]
机构
[1] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA
关键词
D O I
10.4049/jimmunol.167.9.5150
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases that play crucial roles in proteolytic degradation of the extracellular matrix. Aberrant expression of the 92-kDa type IV collagenase (MMP-9) is implicated in the invasion and angiogenesis process of malignant tumors and in inflammatory diseases of the CNS. We investigated the effects of IFN-gamma and IFN-beta, cytokines used for treating some cancers and multiple sclerosis, on MMP-9 expression in human astroglioma and fibrosarcoma cell lines and primary astrocytes. Our results demonstrate that IFN-gamma and IFN-beta significantly inhibit MMP-9 enzymatic activity and protein expression that is induced by PMA and the cytokine TNF-alpha. The inhibitory effects of IFN-gamma and IFN-beta on MMP-9 expression correlate with decreased steady state MMP-9 mRNA levels and suppression of MMP-9 promoter activity. IFN-gamma- and IFN-beta -mediated inhibition of MMP-9 gene expression is dependent on the transcription factor STAT-1 alpha, since IFN-gamma and IFN-beta fail to suppress MMP-9 expression in STAT-1 alpha -deficient primary astrocytes and human fibrosarcoma cells. Reconstitution of human STAT-1 alpha successfully restores the inhibitory effects of IFN-gamma and IFN-beta on MMP-9 gene expression. Thus, these data demonstrate the critical role of STAT-1 alpha in IFN-gamma and IFN-beta suppression of MMP-9 gene expression.
引用
收藏
页码:5150 / 5159
页数:10
相关论文
共 67 条
  • [1] Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells -: A gene therapy approach
    Albini, A
    Marchisone, C
    Del Grosso, F
    Benelli, R
    Masiello, L
    Tacchetti, C
    Bono, M
    Ferrantini, M
    Rozera, C
    Truini, M
    Belardelli, F
    Santi, L
    Noonan, DM
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (04) : 1381 - 1393
  • [2] AMASON BG, 1999, BIOMED PHARMACOTHER, V53, P344
  • [3] Use of interferon for prevention of hepatocellular carcinoma in cirrhotic patients with hepatitis B or hepatitis B virus infection
    Baffis, V
    Shrier, I
    Sherker, AH
    Szilagyi, A
    [J]. ANNALS OF INTERNAL MEDICINE, 1999, 131 (09) : 696 - 701
  • [4] CBP-INDUCED STIMULATION OF C-FOS ACTIVITY IS ABROGATED BY E1A
    BANNISTER, AJ
    KOUZARIDES, T
    [J]. EMBO JOURNAL, 1995, 14 (19) : 4758 - 4762
  • [5] Bannister AJ, 1995, ONCOGENE, V11, P2509
  • [6] Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
    Bergers, G
    Brekken, R
    McMahon, G
    Vu, TH
    Itoh, T
    Tamaki, K
    Tanzawa, K
    Thorpe, P
    Itohara, S
    Werb, Z
    Hanahan, D
    [J]. NATURE CELL BIOLOGY, 2000, 2 (10) : 737 - 744
  • [7] DIRECT EVIDENCE LINKING EXPRESSION OF MATRIX METALLOPROTEINASE-9 (92-KDA GELATINASE/COLLAGENASE) TO THE METASTATIC PHENOTYPE IN TRANSFORMED RAT EMBRYO CELLS
    BERNHARD, EJ
    GRUBER, SB
    MUSCHEL, RJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) : 4293 - 4297
  • [8] Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha
    Bhattacharya, S
    Eckner, R
    Grossman, S
    Oldread, E
    Arany, Z
    DAndrea, A
    Livingston, DM
    [J]. NATURE, 1996, 383 (6598) : 344 - 347
  • [9] Curran S, 1999, J PATHOL, V189, P300, DOI 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO
  • [10] 2-C